Code | 4715E | ||||||||||
MA number | 59/0245/23-S | ||||||||||
Product Form: | cps end 196x240 mg (blis.OPA/Al//PVC//Al) | ||||||||||
MA Status: | R - Valid Marketing Authorisation | ||||||||||
Type of procedure: | Decentralised | ||||||||||
Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 21.11.2023 |
Validity: | 28.11.2028 |
Pediatric indication: | Yes |
Pediatric posology: | Yes |
Pediatric warnings: | Yes |
SPC: | SPC_Dimtelzo_120mg_240mg_10 2023.pdf |
PIL: | PIL_Dimtelzo_120mg_240mg_10 2023.pdf |
Safety feature | Yes |
Data update: | 05.12.2023 |